Augmedix, Inc. (AUGX)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Augmedix, Inc. (AUGX)
Go deeper and ask any question about AUGX
Company Performance
Current Price
as of Sep 13, 2024$2.33
P/E Ratio
N/A
Market Cap
$115.17M
Description
Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. It offers live support including referrals, orders, and reminders that allow clinicians to focus on patient care. The company was founded by Ian Shakil in 2012 and is headquartered in San Francisco, CA.
Metrics
Overview
- HQSan Francisco, CA
- SectorCommercial Services
- IndustryMiscellaneous Commercial Services
- TickerAUGX
- Price$2.33+0.43%
Trading Information
- Market Cap$115.17M
- Float98.49%
- Average Daily Volume (1m)142,073
- Average Daily Volume (3m)878,759
- EPS-$0.47
Company
- Revenue$51.58M
- Rev Growth (1yr)26.75%
- Net Income-$8.45M
- Gross Margin47.24%
- EBITDA Margin-60.81%
- EBITDA-$8.31M
- EV$44.04M
- EV/Revenue0.85
- P/EN/A
- P/S2.41
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset